17 Jan

A Look at Danaher’s 4Q16 Margin Estimates

WRITTEN BY Sheldon Krieger

Danaher’s EBITDA estimates

In 4Q15, Danaher’s (DHR) adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) was ~$1.4 billion, while its EBITDA margin was 23.3%.

In 4Q16, analysts expect DHR to report ~$1.1 billion in EBITDA with an EBITDA margin of 24.1%. A lower EBITDA figure implies lower income from the company’s ongoing operations.

A Look at Danaher’s 4Q16 Margin Estimates

The expected fall in EBITDA is primarily due to DHR’s spin-off of industrial-focused (XLI) Fortive and Industrial Technologies (SIJ) into Fortive Corporation (FTV).

DHR’s Cepheid (CPHD) acquisition may not add value to its EBITDA in 4Q16. More recently, Cepheid has been operating income–negative due to its research and development costs exceeding 21% of its sales. At ~33% of its sales, its selling, general, and administrative expenses are higher than Danaher’s comparative figure of 29%.

Danaher’s 4Q16 and 2016 guidance

On its 3Q16 earnings call, Danaher said that it expected its 4Q16 adjusted EPS (earnings per share) from continuing operations to be in the $1.01–$1.05 range. The company expects its core revenue growth in the quarter to be similar to the levels it achieved in 3Q16.

For 2016, Danaher has raised its adjusted EPS guidance marginally to the $3.57–$3.61 range, reflecting a year-over-year growth expectation of ~20%. In its last earnings call in July 2016, the company guided for 2016 adjusted EPS in the $3.53–$3.60 range.

In the next and final part of this series, we’ll learn about DHR’s financial position and compare its leverage with those of its peers such as 3M Company (MMM) and Roche Holding (RHHBY).

Latest articles

Goldman Sachs (GS) settled a lawsuit that alleged it rigged bond prices. Also, Deutsche Bank agreed to pay a fine of $15 million to settle a lawsuit.

In the November 15 premarket trading session, Amarin Corporation (AMRN) stock rose more than 7%, caused by the FDA positive decision for Vascepa.

In the November 14 trading session, Aurora Cannabis (ACB) stock fell 12.7% from the previous session during after-hours trading.

Strategy Analytics reported that Apple could lead the 5G smartphone market in 2020, outshining Samsung—the current leader in the global 5G market.

This week has been tough for the cannabis sector. Cronos Group and Canopy Growth reported lower-than-expected earnings, and the sector ETFs dropped.

Yesterday, Argus Research upgraded Uber stock from “hold” to “buy.” Let's look at Uber and Lyft’s recent analyst rating changes.